{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:17:01Z","timestamp":1773296221390,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13550-019-0479-8","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T07:04:07Z","timestamp":1548745447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-2418","authenticated-orcid":false,"given":"Magnus","family":"Schou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e4r","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsolt","family":"Cselenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Frid\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christer","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Farde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"issue":"2","key":"479_CR1","doi-asserted-by":"publisher","first-page":"020415","DOI":"10.7189\/jogh.05.020415","volume":"5","author":"D Adeloye","year":"2015","unstructured":"Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratou E, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5(2):020415.","journal-title":"J Glob Health"},{"issue":"5","key":"479_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/clpt.2014.27","volume":"95","author":"P Backman","year":"2014","unstructured":"Backman P, Adelmann H, Petersson G, Jones CB. Advances in inhaled technologies: understanding the therapeutic challenge, predicting clinical performance, and designing the optimal inhaled product. Clin Pharmacol Ther. 2014;95(5):509\u201320.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"479_CR3","first-page":"1603","volume":"41","author":"MS Berridge","year":"2000","unstructured":"Berridge MS, Lee Z, Heald DL. Pulmonary distribution and kinetics of inhaled [11C] triamcinolone acetonide. J Nucl Med. 2000;41(10):1603\u201311.","journal-title":"J Nucl Med"},{"key":"479_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejps.2017.08.021","volume":"113","author":"F Lizal","year":"2018","unstructured":"Lizal F, Jedelsky J, Morgan K, Bauer K, Llop J, Cossio U, et al. Experimental methods for flow and aerosol measurements in human airways and their replicas. Eur J Pharm Sci. 2018;113:95\u2013131.","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"479_CR5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.tips.2006.04.004","volume":"27","author":"CM Lee","year":"2006","unstructured":"Lee CM, Farde L. Using positron emission tomography to facilitate CNS drug development. Trends Pharmacol Sci. 2006;27(6):310\u20136.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"479_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<62::AID-SYN8>3.0.CO;2-1","volume":"35","author":"TJ Visser","year":"2000","unstructured":"Visser TJ, Van Waarde A, Doze P, Wegman T, Vaalburg W. Preclinical testing of N-[(11)c]-methyl-piperidin-4-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate, a novel radioligand for detection of cerebral muscarinic receptors using PET. Synapse. 2000;35(1):62\u20137.","journal-title":"Synapse"},{"issue":"8","key":"479_CR7","first-page":"1270","volume":"40","author":"TJ Visser","year":"1999","unstructured":"Visser TJ, van Waarde A, van der Mark TW, Kraan J, Ensing K, Willemsen AT, et al. Detection of muscarinic receptors in the human lung using PET. J Nucl Med. 1999;40(8):1270\u20136.","journal-title":"J Nucl Med"},{"issue":"1","key":"479_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/jm960374w","volume":"40","author":"TJ Visser","year":"1997","unstructured":"Visser TJ, van Waarde A, Jansen TJ, Visser GM, van der Mark TW, Kraan J, et al. Stereoselective synthesis and biodistribution of potent [11C]-labeled antagonists for positron emission tomography imaging of muscarinic receptors in the airways. J Med Chem. 1997;40(1):117\u201324.","journal-title":"J Med Chem"},{"issue":"2","key":"479_CR9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02245691","volume":"113","author":"P Karlsson","year":"1993","unstructured":"Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, et al. PET examination of [11C] NNC 687 and [11C] NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 1993;113(2):149\u201356.","journal-title":"Psychopharmacology"},{"issue":"10","key":"479_CR10","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1007\/s00259-009-1156-3","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Sjoholm N, Eriksson L, Gulyas B, Halldin C, Farde L. Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT. Eur J Nucl Med Mol Imaging. 2009;36(10):1639\u201350.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"479_CR11","doi-asserted-by":"publisher","first-page":"pyv036","DOI":"10.1093\/ijnp\/pyv036","volume":"18","author":"M Schou","year":"2015","unstructured":"Schou M, Varnas K, Lundquist S, Nakao R, Amini N, Takano A, et al. Large variation in brain exposure of reference CNS drugs: a PET study in nonhuman primates. Int J Neuropsychopharmacol. 2015;18(10):pyv036.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"479_CR12","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/jcbfm.1990.127","volume":"10","author":"J Logan","year":"1990","unstructured":"Logan J, Fowler JS, Volkow ND, Wolf AP, Dewey SL, Schlyer DJ, et al. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(\u2212)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab. 1990;10(5):740\u20137.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"3","key":"479_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1109\/TMI.2003.809597","volume":"22","author":"FE Turkheimer","year":"2003","unstructured":"Turkheimer FE, Aston JA, Banati RB, Riddell C, Cunningham VJ. A linear wavelet filter for parametric imaging with dynamic PET. IEEE Trans Med Imaging. 2003;22(3):289\u2013301.","journal-title":"IEEE Trans Med Imaging"},{"issue":"9","key":"479_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab. 2007;27(9):1533\u20139.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"479_CR15","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.neuroimage.2006.02.053","volume":"32","author":"Z Cselenyi","year":"2006","unstructured":"Cselenyi Z, Olsson H, Halldin C, Gulyas B, Farde L. A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C] FLB 457 and [11C] WAY 100635. NeuroImage. 2006;32(4):1690\u2013708.","journal-title":"NeuroImage"},{"issue":"1","key":"479_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neuroimage.2004.10.037","volume":"25","author":"JA Aston","year":"2005","unstructured":"Aston JA, Gunn RN, Hinz R, Turkheimer FE. Wavelet variance components in image space for spatiotemporal neuroimaging data. NeuroImage. 2005;25(1):159\u201368.","journal-title":"NeuroImage"},{"key":"479_CR17","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/9780470743386.ch12","volume-title":"Random-effects model. Introduction to meta-analysis","author":"MHL Borenstein","year":"2009","unstructured":"Borenstein MHL, Higgins JPT, Rothstein HR. Random-effects model. Introduction to meta-analysis. Chichester: John Wiley & Sons Ltd; 2009. p. 69\u201375."},{"key":"479_CR18","volume-title":"Application of magnetic resonance to the study of lung","author":"A Cutillo","year":"1996","unstructured":"Cutillo A. Application of magnetic resonance to the study of lung. Armonk, New York: Futura; 1996."},{"issue":"6","key":"479_CR19","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1111\/j.1476-5381.2012.01881.x","volume":"166","author":"T Ikeda","year":"2012","unstructured":"Ikeda T, Anisuzzaman AS, Yoshiki H, Sasaki M, Koshiji T, Uwada J, et al. Regional quantification of muscarinic acetylcholine receptors and beta-adrenoceptors in human airways. Br J Pharmacol. 2012;166(6):1804\u201314.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"479_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13054-017-1844-5","volume":"21","author":"J Dugernier","year":"2017","unstructured":"Dugernier J, Ehrmann S, Sottiaux T, Roeseler J, Wittebole X, Dugernier T, et al. Aerosol delivery during invasive mechanical ventilation: a systematic review. Crit Care. 2017;21(1):264.","journal-title":"Crit Care"},{"issue":"2","key":"479_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/0091-6749(92)90317-U","volume":"89","author":"BL Laube","year":"1992","unstructured":"Laube BL, Norman PS, Adams GK 3rd. The effect of aerosol distribution on airway responsiveness to inhaled methacholine in patients with asthma. J Allergy Clin Immunol. 1992;89(2):510\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"479_CR22","unstructured":"Garber J. Guide for the care and use of laboratory animals. In: Garber J, editor. The National Academies Collection: reports funded by National Institutes of Health. 8th ed. Washington (DC): The National Academies Press; 2011."}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13550-019-0479-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-019-0479-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T20:29:07Z","timestamp":1580243347000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-019-0479-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1186\/s13550-019-0479-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"7 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Animal Ethics Committee of the Swedish Animal Welfare Agency (Dnr 452\/11) and was performed according to the \u201cGuidelines for planning, conducting and documenting experimental research\u201d (Dnr 4820\/06-600) of Karolinska Institutet, the \u201cGuide for the Care and Use of Laboratory Animals\u201d [], the AstraZeneca Bioethical Policy and the EU Directive 2010\/63\/EU on the protection of animals used for scientific purposes.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MF, LF. MS, PE, ZC, MF and LF are employees at AstraZeneca. No other potential competing interest relevant to this article exist.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"9"}}